$3.29 Billion is the total value of QVT Financial LP's 85 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXGT | AXOVANT SCIENCES LTD | $931,500,000 | -11.3% | 75,000,000 | 0.0% | 28.29% | -28.5% | |
| MICROCHIP TECHNOLOGY INCsdcv 2.125%12/1 | $85,401,000 | +3.7% | 31,764,000 | 0.0% | 2.59% | -16.5% | ||
| TAL ED GROUPnote 2.500% 5/1 | $77,686,000 | -1.6% | 29,000,000 | 0.0% | 2.36% | -20.7% | ||
| VERISIGN INCsdcv 3.250% 8/1 | $77,632,000 | -2.3% | 34,600,000 | 0.0% | 2.36% | -21.2% | ||
| ABUS | ARBUTUS BIOPHARMA CORP | $39,233,000 | -28.8% | 16,013,540 | 0.0% | 1.19% | -42.6% | |
| COG | CABOT OIL & GAS CORP | $19,266,000 | -9.5% | 824,742 | 0.0% | 0.58% | -27.1% | |
| NAT | NORDIC AMERICAN TANKERS LIMIput | $14,763,000 | -16.9% | 1,757,500 | 0.0% | 0.45% | -33.1% | |
| TSM | TAIWAN SEMICONDUCTOR MFG LTDput | $11,500,000 | -6.0% | 400,000 | 0.0% | 0.35% | -24.3% | |
| WEBMD HEALTH CORPnote 2.500% 1/3 | $11,408,000 | -0.7% | 11,000,000 | 0.0% | 0.35% | -20.1% | ||
| AVXS | AVEXIS INC | $10,734,000 | +15.9% | 224,756 | 0.0% | 0.33% | -6.6% | |
| AR | ANTERO RES CORP | $8,831,000 | -12.2% | 373,413 | 0.0% | 0.27% | -29.3% | |
| YY | YY INC | $7,517,000 | -26.0% | 190,700 | 0.0% | 0.23% | -40.5% | |
| ZXAIY | CHINA ZENIX AUTO INTL LTDads | $5,624,000 | -3.3% | 6,074,805 | 0.0% | 0.17% | -21.9% | |
| BGNE | BEIGENE LTDsponsored adr | $5,161,000 | -1.5% | 170,000 | 0.0% | 0.16% | -20.3% | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $3,962,000 | -78.9% | 2,556,256 | 0.0% | 0.12% | -83.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
| 13F-HR | 2023-05-15 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.